Avantor Net Profit Margin 2018-2024 | AVTR
Current and historical net profit margin for Avantor (AVTR) from 2018 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Avantor net profit margin for the three months ending June 30, 2024 was .
| Avantor Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-06-30 | $6.83B | $0.36B | 5.27% |
| 2024-03-31 | $6.87B | $0.26B | 3.79% |
| 2023-12-31 | $6.97B | $0.32B | 4.62% |
| 2023-09-30 | $7.04B | $0.37B | 5.19% |
| 2023-06-30 | $7.18B | $0.42B | 5.91% |
| 2023-03-31 | $7.34B | $0.61B | 8.31% |
| 2022-12-31 | $7.51B | $0.66B | 8.81% |
| 2022-09-30 | $7.63B | $0.60B | 7.84% |
| 2022-06-30 | $7.60B | $0.57B | 7.52% |
| 2022-03-31 | $7.55B | $0.54B | 7.09% |
| 2021-12-31 | $7.39B | $0.51B | 6.89% |
| 2021-09-30 | $7.27B | $0.47B | 6.41% |
| 2021-06-30 | $7.04B | $0.27B | 3.79% |
| 2021-03-31 | $6.66B | $0.17B | 2.54% |
| 2020-12-31 | $6.39B | $0.05B | 0.81% |
| 2020-09-30 | $6.13B | $0.07B | 1.18% |
| 2020-06-30 | $6.03B | $0.14B | 2.26% |
| 2020-03-31 | $6.08B | $-0.23B | -3.70% |
| 2019-12-31 | $6.04B | $-0.33B | -5.53% |
| 2019-06-30 | $4.51B | $-0.43B | -9.52% |
| 2019-03-31 | $4.45B | $-0.21B | -4.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $17.560B | $6.967B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.497B | 14.81 |
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Revvity (RVTY) | United States | $15.548B | 27.23 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| HealthEquity (HQY) | United States | $6.980B | 37.88 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Teladoc Health (TDOC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Pediatrix Medical (MD) | United States | $0.967B | 10.52 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |